Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
Rev Neurol
    April 2022
  1. LABOS E, Guajardo ME, Soderlund ME, Pagotto V, et al
    [Vascular damage and cognitive-functional performance in a population with mild cognitive impairment].
    Rev Neurol. 2022;74:209-218.
    >> Share

    March 2022
  2. DAL-RE R
    [The European Medicines Agency rejects the authorization of aducanumab for Alzheimer's disease].
    Rev Neurol. 2022;74:207-208.
    >> Share

    October 2021
  3. DAL-RE R
    [Aducanumab approval for Alzheimer's disease in the USA: the surrender of science].
    Rev Neurol. 2021;73:296-297.
    >> Share

    June 2021
  4. MONGE-GARCIA V, Llorca-Tolon L, Gasparini-Berenguer R, Monge-Argiles JA, et al
    [Role of the Ass1-42/Ass1-40 ratio in the concept 'Alzheimer's disease contributes to mild cognitive impairment'].
    Rev Neurol. 2021;72:371-376.
    >> Share

    November 2020
  5. DEVI-BASTIDA J, Catala-Sune N, Jofre-Font S
    [Bilingualism as a factor in the protection of Alzheimer's disease: a systematic review].
    Rev Neurol. 2020;71:353-364.
    >> Share

    July 2020
  6. MONTOYA-PEDRON A, Ocana-Montoya CM, Bolano-Diaz GA
    [P300 cognitive event-related potentials in the diagnosis and classification of possible Alzheimer-type neurocognitive disorders].
    Rev Neurol. 2020;71:11-18.
    >> Share

    April 2020
  7. LOPEZ C, Sanchez JL, Martin J
    [Exploratory analysis of the influence of cognitive reserve on the benefits of cognitive stimulation therapy in patients with sporadic late-onset Alzheimer's disease].
    Rev Neurol. 2020;70:271-281.
    >> Share

    November 2019
  8. COSSINI FC, Cuesta C, Rubinstein W, Politis DG, et al
    [Recognition of basic emotions and their main confusers in Alzheimer-type dementia].
    Rev Neurol. 2019;69:363-369.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016